Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01328431 · ClinicalTrials.gov registry record · NA

Treating Low-Income Smokers in the Hospital Emergency Department

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
780
Enrollment target

NCT01328431: Completed NA study, sponsored by Yale University.

NCT01328431 is a NA study that has completed, run by Yale University. The registered enrollment target is 780 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01328431, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
780 participants
Enrollment target

Study Summary

This study will test the effectiveness of an Emergency Department (ED) initiated tobacco intervention which includes counseling and medication. Our proposed intervention combines a Brief Negotiated Interview (BNI) with initiation of nicotine patch and gum in the ED, as well as a faxed referral to the state's Smokers' Quitline. A 6 week supply of nicotine patches and nicotine gum are provided to subjects in the intervention arm. Subjects randomized to the control arm will receive a brochure from the state's Smokers' Quitline only. The primary hypothesis is that the intervention will be superior to the control condition in reducing self-reported and biochemically verified 7-day tobacco abstinence at 3 months.

Primary Outcome

Biochemical verification means a breathalyzer reading for carbon monoxide.

Interventions

  • OTHER Brief Intervention with NRT Initiation

Trial Details

FieldValue
Enrollment Target 780 participants
Start Date 2010-10
Est. Completion 2014-01
Phase NA
Yale University

1,492 total trials

What the finished NCT01328431 record still lists

NCT01328431 is an interventional study that assigns participants to a tested intervention. The registered 780 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% lower).

The record links to 0 conditions, and to 1 intervention - of which Brief Intervention with NRT Initiation is the first listed.

NCT01328431 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01328431 about?

NCT01328431 is a clinical study titled "Treating Low-Income Smokers in the Hospital Emergency Department". This study will test the effectiveness of an Emergency Department (ED) initiated tobacco intervention which includes counseling and medication. Our proposed intervention combines a Brief Negotiated Interview (BNI) with initiation of nicotine patch and gum in the ED, as well as a faxed referral to th...

What is the current status of trial NCT01328431?

This trial is currently completed. It is a NA study. The enrollment target is 780 participants. The study started on 2010-10. Estimated completion is 2014-01.

What interventions are being tested in trial NCT01328431?

The interventions under investigation include: Brief Intervention with NRT Initiation (OTHER).

Who is sponsoring clinical trial NCT01328431?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01328431's enrollment target sits among peer trials

780 141st of 2000 higher than 1,859 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05046613 · 780 participants

    Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

  • NCT05100862 · 780 participants · Phase 3

    A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  • NCT05513872 · 780 participants · Phase 1

    Overcoming Nicotine Dependence to Enable Quitting

  • NCT06310031 · 780 participants · NA

    Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01328431, the US trial registry maintained by the National Library of Medicine. NCT01328431 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.